The Indian arm of British-Swedish pharma giant AstraZeneca Pharma gained 2.34 per cent to Rs 4,545.10 after the vaccine manufactured by the company got a nod from UK drug regulators. Chances are it may get India approval soon.
– Stocks-Markets-Economic Times